Why use EDC for neutraceutical clinical studies?

Why use EDC for Neutraceutical clinical studies? Beverage studies and ingredient and supplement clinical trials are typically faster moving than their pharma or medical device counterparts. As such the ability to set up a study quickly, input date efficiently and then manage and report on that data are critical to facilitate a rapid turnaround. For these reasons, historically EDC systems have been avoided by the industry for neutraceutical studies, especially as budgets are also typically significantly less and compliance has been less onerous.

In simple terms, EDC can help streamline the food study process from start to finish saving a lot of time and money – whilst providing secure, manageable and reportable data in a timely fashion. Using an FDA compliant system built to GCP standards also helps ensure regulatory requirements are met. In the modern world, providing the solution is cost-effective, it makes no sense not to use EDC. But ideally, it needs to do everything you require to, entirely in one integrated system.